X4 Pharmaceuticals, Inc. (XFOR)
3.10
-0.15
(-4.62%)
USD |
NASDAQ |
Oct 27, 11:28
X4 Pharmaceuticals Price : 3.10 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 3.26 | 3.30 | 3.14 | 3.25 | 701647.0 |
| Oct 23, 2026 | 3.16 | 3.25 | 3.02 | 3.24 | 536761.0 |
| Oct 22, 2026 | 2.99 | 3.280 | 2.96 | 3.20 | 594590.0 |
| Oct 21, 2026 | 3.02 | 3.12 | 2.875 | 3.01 | 406915.0 |
| Oct 20, 2026 | 2.79 | 3.07 | 2.77 | 3.02 | 593333.0 |
| Oct 19, 2026 | 2.60 | 2.82 | 2.58 | 2.75 | 602984.0 |
| Oct 16, 2026 | 2.64 | 2.71 | 2.52 | 2.59 | 967583.0 |
| Oct 15, 2026 | 2.48 | 2.655 | 2.475 | 2.64 | 549838.0 |
| Oct 14, 2026 | 2.54 | 2.55 | 2.43 | 2.45 | 705744.0 |
| Oct 13, 2026 | 2.81 | 2.83 | 2.59 | 2.60 | 439603.0 |
| Oct 12, 2026 | 2.89 | 2.93 | 2.81 | 2.82 | 404694.0 |
| Oct 09, 2026 | 2.83 | 2.965 | 2.815 | 2.91 | 541229.0 |
| Oct 08, 2026 | 2.77 | 2.81 | 2.70 | 2.79 | 836503.0 |
| Oct 07, 2026 | 2.74 | 2.86 | 2.70 | 2.81 | 435382.0 |
| Oct 06, 2026 | 2.90 | 2.90 | 2.70 | 2.77 | 642468.0 |
| Oct 05, 2026 | 2.88 | 2.935 | 2.73 | 2.90 | 698104.0 |
| Oct 02, 2026 | 2.86 | 2.86 | 2.745 | 2.83 | 911404.0 |
| Oct 01, 2026 | 2.89 | 2.95 | 2.82 | 2.83 | 501492.0 |
| Sep 30, 2026 | 2.93 | 2.935 | 2.845 | 2.90 | 1.765M |
| Sep 29, 2026 | 3.01 | 3.055 | 2.895 | 2.90 | 1.710M |
| Sep 28, 2026 | 2.996 | 3.04 | 2.81 | 3.015 | 838400.0 |
| Sep 25, 2026 | 2.98 | 3.083 | 2.965 | 3.01 | 1.857M |
| Sep 24, 2026 | 3.10 | 3.10 | 2.955 | 3.00 | 973684.0 |
| Sep 23, 2026 | 3.41 | 3.42 | 3.035 | 3.11 | 2.310M |
| Sep 22, 2026 | 3.52 | 3.57 | 3.40 | 3.43 | 923763.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sarepta Therapeutics, Inc. | 18.36 |
| Arrowhead Pharmaceuticals, Inc. | 60.08 |
| Oncolytics Biotech, Inc. | 0.487 |
| Sangamo Therapeutics, Inc. | 0.1161 |
| Anixa Biosciences, Inc. | 3.215 |
Price Related Metrics
| PS Ratio | 19.88 |
| Price to Book Value | 1.917 |
| Earnings Yield | -38.50% |
| Market Cap | 297.95M |